Trial Profile
Personalised Medicine With IgGAM Compared With Standard of Care for Treatment of Peritonitis After Infectious Source Control (the PEPPER Trial): a Randomised, Controlled Trial
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Feb 2024
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Sepsis; Septic shock
- Focus Therapeutic Use
- Acronyms PEPPER
- 29 Jan 2024 Planned End Date changed from 1 Jan 2027 to 1 Mar 2028.
- 29 Jan 2024 Planned primary completion date changed from 1 Sep 2026 to 1 Sep 2027.
- 23 Jan 2024 Status changed from suspended to recruiting.